Alzprotect: The American food and drug administration (FDA) has granted azp2006 the orphan drug designation for the treatment of progressive supranuclear palsy (PSP)

5th May 2017 Uncategorised 0

B3C newswire

More: Alzprotect: The American food and drug administration (FDA) has granted azp2006 the orphan drug designation for the treatment of progressive supranuclear palsy (PSP)
Source: MDlinx